NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA). Shareholders who purchased shares of SANA ...

A biotech firm which received €4.7 million in support from the European Union's Just Transition Fund has announced that it will forgo that support. Biotech startup ÄIO had planned to build a showcase ...

bluebird bio Inc. (NASDAQ:BLUE), a biotechnology company with a market capitalization of approximately $40 million, focuses on developing treatments for severe genetic diseases and cancer.

Several biotech firms have gone public this year, and those focused on obesity treatments, gene therapies, and more have high expectations. Insiders, especially beneficial owners, have been ...

The layoffs went into effect Friday. A global biotech company is cutting 108 jobs at a Santa Clara branch, according to a notice filed with the state. Roche Molecular Systems Inc. in Santa Clara ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at whereGenmab A/S (NASDAQ:GMAB) stands against other most ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where Exelixis, Inc. (NASDAQ:EXEL) stands against other most ...

The stock value and growth potential of a biotech firm depend on the type of diseases it treats. This might also include the research that the firm does as it supports other companies, diseases or ...

Sana is a biotechnology company that develops ex vivo and in vivo cell engineering programs to purportedly revolutionize treatment across a broad array of therapeutic areas with unmet treatment ...

Declining interest rates could also reopen the IPO window for biotech firms. Meanwhile, innovations in gene editing, AI-powered drug discovery, and precision medicine are driving biotech’s ...